Sage Journals: Discover world-class research

Abstract

Objective

To explore the clinical and genetic characteristics of CNTNAP1 gene-related Lethal Congenital Contracture Syndrome Type 7 (LCCS7) and Congenital Hypomyelinating Neuropathy Type 3 (CHN3).

Methods

The clinical data and genetic test results of one patient were retrospectively analyzed. This patient had CNTNAP1 gene-related LCCS7 and admitted to hospital in 2013. A literature review was also conducted by searching for the CNTNAP1 gene or “Lethal Congenital Contracture Syndrome Type 7” or “Congenital Hypomyelinating Neuropathy Type 3” in databases such as CNKI, Wanfang database and PubMed. The clinical and genetic characteristics of CNTNAP1-related LCCS7 and CHN3 diseases were summarized.

Results

The proband was a female. Prenatal ultrasound showed polyhydramnios, few swallowing and respiratory movements, and a fixed fetal posture. She was born at 33 weeks due to premature rupture of membranes. After birth, she exhibited no cry, respiratory distress, and low muscle tone. She received a series of treatments in the obstetrics department, and was ultimately transferred to neonatology of our hospital due to “respiratory distress in a premature infant.” Since the fetus had abnormalities in utero, prenatal family exome sequencing was performed, which revealed two pathogenic mutations, c.1699G > T and c.789G > T, in the CNTNAP1 gene. c.1699G > T was inherited from the father, and c.789G > T was inherited from the mother, confirming compound heterozygosity. The infant died on the 13th day after premature birth. We retrieved 16 reports of CNTNAP1 gene-related LCCS7/CHN3 with 44 patients, and a total of 45 patients were analyzed combined with 1 case in this study. The main clinical manifestations included polyhydramnios (29 cases), fetal akinesia (12 cases), respiratory distress (35 cases), hypotonia (42 cases), hypomyelination (28 cases), and seizures (11 cases).

Conclusion

the CNTNAP1 gene test can be considered for polyhydramnios, fetal akinesia, postnatal respiratory distress, hypotonia, and neurological abnormalities.

Keywords

polyhydramnios fetal akinesia espiratory distress

Get full access to this article

View all access options for this article.

References

Bellen

Beckstead

, et al. Neurexin IV, caspr and paranodin—novel members of the neurexin family: encounters of axons and glia. Trends Neurosci 1998; 21: 444–449.

Bhat

Rios

, et al. Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron 2001; 30: 369–383.

Mitchell

. The genetics of neurodevelopmental disease. Curr Opin Neurobiol 2011; 21: 197–203.

Yang

Tang

, et al. Mutations of CNTNAP1 led to defects in neuronal development. JCI Insight 2020; 5: e135697.

Richards

Aziz

Bale

, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomicsand the association for molecular pathology. Genet Med 2015; 17: 405–423.

Khan

Umair

Abbas

, et al. Overlapping neurological phenotypes in two extended consanguineous families with novel variants in the CNTNAP1 and ADGRG1 genes. J Gene Med 2023; 25: e3513.

Garel

Lesca

Ville

, et al. CNTNAP1-encephalopathy: six novel patients surviving the neonatal period. Eur J Paediatr Neurol 2022; 37: 98–104.

Analysis of CNTNAP1 gene variation in a family with fatal congenital contracture syndrome type 7.pdf.

Wirth

Tranchant

Drouot

, et al. Increased diagnostic yield in complex dystonia through exome sequencing. Parkinsonism Relat Disord 2020; 74: 50–56.

10.

Sabbagh

Antoun

Mégarbané

. CNTNAP1 Mutations and their clinical presentations: new case report and systematic review. Case Rep Med 2020; 2020: 8795607.

11.

Freed

Weiss

Malouf

, et al. CNTNAP1 Mutations in an adult with Charcot Marie Tooth disease. Muscle Nerve 2019; 60: E28.

12.

Lesmana

Lee

Hosseini

, et al. CNTNAP1-related Congenital hypomyelinating neuropathy. Pediatr Neurol 2019; 93: 43–49.

13.

Low

Stals

Caswell

, et al. Phenotype of CNTNAP1: a study of patients demonstrating a specific severe congenital hypomyelinating neuropathy with survival beyond infancy. Eur J Hum Genet 2018; 26: 796–807.

14.

Conant

Curiel

Pizzino

, et al. Absence of axoglial paranodal junctions in a child with CNTNAP1 mutations, hypomyelination, and arthrogryposis. J Child Neurol 2018; 33: 642–650.

15.

Nizon

Cogne

Vallat

, et al. Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy. Eur J Hum Genet 2017; 25: 150–152.

16.

Vallat

J-M

Nizon

Magee

, et al. Contactin-associated protein 1 (CNTNAP1) mutations induce characteristic lesions of the paranodal region. J Neuropathol Exp Neurol 2016; 75: nlw093.

17.

Hengel

Magee

Mahanjah

, et al. CNTNAP1 Mutations cause CNS hypomyelination and neuropathy with or without arthrogryposis. Neurol Genet 2017; 3: e144.

18.

Lakhani

Doan

Almureikhi

, et al. Identification of a novel CNTNAP1 mutation causing arthrogryposis multiplex congenita with cerebral and cerebellar atrophy. Eur J Med Genet 2017; 60: 245–249.

19.

Mehta

Küspert

Bale

, et al. Novel mutation in CNTNAP1 results in congenital hypomyelinating neuropathy. Muscle Nerve 2017; 55: 761–765.

20.

Laquérriere

Maluenda

Camus

, et al. Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects. Hum Mol Genet 2014; 23: 2279–2289.

A case of CNTNAP1 gene-related abnormality and literature review